BFRIW (Biofrontera) OCF Margin %: -0.69% (As of Mar. 2026)


BFRIW Biofrontera Inc BFRIW
44 GF Score
Price $0.06
! 4 Warning Signs
View Full Analysis

What is Biofrontera OCF Margin %?

Biofrontera BFRIW 44 OCF Margin % is -0.69% as of Mar. 2026. GuruFocus rates BFRIW with a GF Score™ of 44/100. The stock has 4 warning signs investors should review. Among 959 Drug Manufacturers companies, Biofrontera ranks worse than 87.17% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Biofrontera's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.07 Mil. Biofrontera's Revenue for the three months ended in Mar. 2026 was $10.08 Mil. Therefore, Biofrontera's OCF Margin % for the quarter that ended in Mar. 2026 was -0.69%.

As of today, Biofrontera's current OCF Yield % is -72.75%.

The historical rank and industry rank for Biofrontera's OCF Margin % or its related term are showing as below:


During the past 7 years, the highest OCF Margin % of Biofrontera was -27.52%. The lowest was -143.91%. And the median was -65.62%.

BFRIW's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.95
* Ranked among companies with meaningful OCF Margin % only.

Biofrontera OCF Margin % Related Terms

Biofrontera OCF Margin % Historical Data

* Premium members only.

The historical data trend for Biofrontera's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofrontera OCF Margin % Chart

Biofrontera Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -110.85 -56.49 -73.07 -27.52 -32.04

Biofrontera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.94 -33.72 -54.71 -13.89 -0.69
BFRIW
44GF Score
Biofrontera Inc BFRIW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofrontera OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Biofrontera's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.361/41.705
=-32.04 %

Biofrontera's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.07/10.084
=-0.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -0.69% mean?
Biofrontera (BFRIW) has a OCF Margin % of -0.69% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biofrontera and its competitors. According to the industry distribution chart, Biofrontera ranks #836 out of 959 companies in the Drug Manufacturers industry, placing it in the top 87.2%.
Is Biofrontera's OCF Margin % too high?
Biofrontera's current OCF Margin % is -0.69%. Based on the distribution chart, Biofrontera ranks #836 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Biofrontera has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Biofrontera's OCF Margin % compare to AKAN and CABR?
According to the Drug Manufacturers industry distribution chart, Biofrontera ranks #836 out of 959 companies for OCF Margin %. This places Biofrontera in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biofrontera and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biofrontera's current OCF Margin % is -0.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofrontera stock overvalued right now?
Biofrontera (BFRIW) has a current OCF Margin % of -0.69%. The current OCF Margin % is -0.69%. Biofrontera's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Biofrontera (BFRIW), the current OCF Margin % is -0.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biofrontera Business Description

Other Exchanges BFRI:USA
Address 660 Main Street, 1st Floor, Woburn, MA, USA, 01801
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
44GF Score

Get the complete analysis for BFRIW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price